Concizumab (Anti-TFPI)
Product Specifications
CAS Number
1312299-39-0
Synonyms
NN 7415, mAb 2021, Anti-TFPI Recombinant Antibody
SKU
C00153-1mg
Additionnal Information
Concizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1046754-01 0.02 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Putative antitoxin VapB13 (vapB17)
Ask
View Details MBS1046754-02 0.1 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Putative antitoxin VapB13 (vapB17)
Ask
View Details 
MBS1046754-03 0.02 mg (Yeast)
Recombinant Archaeoglobus fulgidus Putative antitoxin VapB13 (vapB17)
Ask
View Details 
MBS1046754-04 0.1 mg (Yeast)
Recombinant Archaeoglobus fulgidus Putative antitoxin VapB13 (vapB17)
Ask
View Details MBS1046754-05 0.02 mg (Baculovirus)
Recombinant Archaeoglobus fulgidus Putative antitoxin VapB13 (vapB17)
Ask
View Details MBS1046754-06 1 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Putative antitoxin VapB13 (vapB17)
Ask
View Details